Ditchcarbon
  • Contact
  1. Organizations
  2. Biofirst S.A.
Public Profile
BE
updated a month ago

Biofirst S.A. Sustainability Profile

Company website

Biofirst S.A., headquartered in Belgium, is a prominent player in the biotechnology industry, specialising in innovative solutions for healthcare and agriculture. Founded in the early 2000s, the company has achieved significant milestones, establishing itself as a leader in the development of biopharmaceuticals and bio-based products. With a focus on sustainable practices, Biofirst S.A. offers a range of unique products, including advanced biopesticides and biofertilisers, designed to enhance crop yield while minimising environmental impact. The company’s commitment to research and development has positioned it at the forefront of the market, earning recognition for its contributions to sustainable agriculture. Operating primarily in Europe, Biofirst S.A. continues to expand its influence, driven by a dedication to innovation and quality. Its notable achievements underscore its role as a trusted partner in the biotechnology sector, committed to advancing both health and environmental sustainability.

DitchCarbon Score

How does Biofirst S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

14

Industry Average

Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

0

Industry Benchmark

Biofirst S.A.'s score of 14 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Biofirst S.A.'s reported carbon emissions

In 2024, Biofirst S.A. reported total carbon emissions of approximately 27,719,300 kg CO2e from Scope 3, with significant contributions from waste generated in operations, amounting to about 2,860,400 kg CO2e. The company also recorded Scope 1 and 2 emissions of approximately 24,394,000 kg CO2e. This data reflects a substantial increase in emissions compared to 2019, when total Scope 3 emissions were about 1,375,000 kg CO2e, and Scope 1 and 2 emissions were approximately 19,867,000 kg CO2e. Biofirst S.A. is a current subsidiary of Floridienne S.A., which influences its emissions reporting. However, there are no specific reduction targets or climate pledges disclosed by Biofirst S.A. at this time. The absence of defined reduction initiatives suggests a need for enhanced climate commitments within the organisation.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192024
Scope 1
-
-
Scope 2
-
-
Scope 3
1,375,000
000,000,000

How Carbon Intensive is Biofirst S.A.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Biofirst S.A.'s primary industry is , which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Biofirst S.A.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Biofirst S.A. is in BE, which has a very low grid carbon intensity relative to other regions.

Biofirst S.A.'s Scope 3 Categories Breakdown

Biofirst S.A.'s Scope 3 emissions, which increased significantly last year and increased significantly since 2019, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Waste Generated in Operations" being the primary emissions source at 10% of Scope 3 emissions.

Top Scope 3 Categories

2024
Waste Generated in Operations
10%

Biofirst S.A.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Biofirst S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Biofirst S.A.'s Emissions with Industry Peers

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 minutes ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 minutes ago

Vertex Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 minutes ago

Genentech

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 minutes ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 minutes ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 minutes ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.5
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy